| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,606 |
9,339 |
$1.17M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,354 |
6,781 |
$726K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,179 |
1,579 |
$471K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,414 |
2,809 |
$400K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,384 |
1,098 |
$162K |
| 70450 |
Computed tomography, head or brain; without contrast material |
564 |
422 |
$104K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,227 |
11,332 |
$96K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,223 |
1,019 |
$92K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,138 |
1,087 |
$49K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,125 |
1,075 |
$31K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
211 |
125 |
$31K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
525 |
119 |
$26K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
129 |
72 |
$23K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
114 |
76 |
$20K |
| 87480 |
|
553 |
517 |
$13K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
619 |
581 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
9,233 |
7,461 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
218 |
76 |
$10K |
| 84484 |
|
2,739 |
2,193 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,674 |
13,267 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
3,035 |
2,555 |
$9K |
| 87660 |
|
584 |
548 |
$9K |
| 87510 |
|
553 |
517 |
$8K |
| G0378 |
Hospital observation service, per hour |
308 |
127 |
$8K |
| 80053 |
Comprehensive metabolic panel |
1,098 |
645 |
$7K |
| 80076 |
|
1,770 |
1,467 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,351 |
4,483 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,697 |
3,083 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
310 |
238 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
41 |
25 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
199 |
49 |
$3K |
| 81001 |
|
6,947 |
5,915 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
224 |
147 |
$3K |
| 73030 |
|
79 |
42 |
$3K |
| 80061 |
Lipid panel |
170 |
127 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
156 |
154 |
$2K |
| 84439 |
|
95 |
65 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
122 |
89 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
70 |
50 |
$2K |
| 87481 |
|
120 |
119 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,428 |
1,123 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
57 |
13 |
$1K |
| 72100 |
|
47 |
31 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
30 |
18 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
162 |
90 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
26 |
24 |
$961.69 |
| 86902 |
|
31 |
25 |
$948.46 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
349 |
239 |
$935.50 |
| 74018 |
|
57 |
40 |
$840.82 |
| 82553 |
|
64 |
53 |
$778.56 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,562 |
1,115 |
$754.34 |
| 85027 |
|
126 |
72 |
$684.80 |
| 73562 |
|
21 |
14 |
$674.89 |
| 83735 |
|
165 |
84 |
$635.63 |
| 87150 |
|
23 |
14 |
$603.09 |
| 83690 |
|
2,001 |
1,578 |
$435.07 |
| 83540 |
|
38 |
30 |
$396.01 |
| 97161 |
|
19 |
15 |
$391.02 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,261 |
829 |
$375.81 |
| 76000 |
|
60 |
54 |
$314.63 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
206 |
175 |
$296.32 |
| 85379 |
|
316 |
251 |
$279.32 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
18 |
17 |
$272.43 |
| 86850 |
|
13 |
12 |
$254.94 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
18 |
17 |
$240.93 |
| 86901 |
|
31 |
25 |
$235.90 |
| 85610 |
|
517 |
342 |
$232.61 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
16 |
12 |
$217.30 |
| 81025 |
|
573 |
422 |
$161.66 |
| 82150 |
|
562 |
475 |
$153.53 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
709 |
402 |
$150.00 |
| 86140 |
|
22 |
17 |
$129.08 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
48 |
27 |
$123.16 |
| 84703 |
|
191 |
114 |
$103.31 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
22 |
16 |
$97.33 |
| 83605 |
|
259 |
140 |
$96.96 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
88 |
48 |
$77.18 |
| 87186 |
|
91 |
38 |
$65.33 |
| 83880 |
|
78 |
35 |
$41.44 |
| 85730 |
|
296 |
172 |
$39.26 |
| 87081 |
|
14 |
13 |
$34.70 |
| 82550 |
|
81 |
67 |
$32.56 |
| 85652 |
|
16 |
13 |
$31.55 |
| A9270 |
Non-covered item or service |
1,343 |
101 |
$25.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
434 |
235 |
$18.75 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
340 |
182 |
$18.45 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
137 |
60 |
$17.82 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
120 |
54 |
$16.96 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20 |
13 |
$15.20 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
177 |
80 |
$15.18 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
524 |
280 |
$9.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
292 |
134 |
$8.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
62 |
25 |
$6.19 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
316 |
160 |
$1.82 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
246 |
124 |
$1.02 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
39 |
29 |
$0.30 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
73 |
42 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
31 |
17 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
30 |
18 |
$0.00 |
| 94760 |
|
2,107 |
1,699 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
290 |
148 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
86 |
47 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
13 |
12 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$0.00 |
| 96376 |
|
47 |
17 |
$0.00 |